Posted on July 31, 2019 PENDOPHARM launches ELEVIEWTM in Canada (submucosal injectable composition 10mL) Read More
Posted on December 7, 2018 GLATECTTM IS NOW COVERED BY THE PROVINCIAL DRUG PLAN IN BRITISH COLUMBIA FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS). Read More
Posted on November 12, 2018 PENDOPHARM, a division of PHARMASCIENCE INC wins the D.W. BOLE award Read More
Posted on February 20, 2018 PENDOPHARM a division of Pharmascience signs an agreement with Cosmo Pharmaceuticals Read More
Posted on October 5, 2017 PENDOPHARM launches GLATECT, a new treatment option for MS patients Read More